BAAM
DNLI icon

Baker Avenue Asset Management’s Denali Therapeutics DNLI Stock Holding History

Baker Avenue Asset Management’s Portfolio DNLI Stock Details DNLI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-22
Closed -$612 – 1637
2022
Q4 		$612 Buy
+22
New +$612 ﹤0.01% 1242